We are live on ! Find out more
IP

Intellectus Partners Portfolio holdings

AUM $578M
1-Year Est. Return 49.48%
This Fund
S&P 500
This Quarter Est. Return
+7.3%
1 Year Est. Return
+49.48%
3 Year Est. Return
+157.34%
5 Year Est. Return
+153.66%
10 Year Est. Return
–
AUM
$443M
AUM Growth
+$79.4M
Cap. Flow
+$58.1M
Cap. Flow %
13.09%
Top 10 Hldgs %
28.62%
Holding
280
New
38
Increased
121
Reduced
93
Closed
8
Avg Time Held Equity + Options
7.3 quarters
Top 10 Avg Time Held Equity + Options
7.5 quarters
Top 20 Avg Time Held Equity + Options
7.9 quarters
Avg Time Held Equity only
7.4 quarters
Top 10 Avg Time Held Equity only
7.5 quarters
Top 20 Avg Time Held Equity only
7.9 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 19.51%
2 Healthcare 19.33%
3 Technology 19.31%
4 Consumer Discretionary 12.84%
5 Communication Services 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MO icon
176
Altria Group
MO
$119B
$624K 0.14%
12,849
+223
+2% +$11K
2017 Q2
16 quarters
UL icon
177
Unilever
UL
$135B
$619K 0.14%
9,406
-17
-0.2% -$1.13K
2020 Q4
2 quarters
MCK icon
178
McKesson
MCK
$112B
$617K 0.14%
3,218
+30
+0.9% +$5.79K
2016 Q4
18 quarters
LBRDK icon
179
DELISTED
Liberty Broadband Class C
LBRDK
$615K 0.14%
3,542
+8
+0.2% +$1.29K
2016 Q4
18 quarters
GSAT icon
180
Globalstar
GSAT
$10.7B
$614K 0.14%
23,000
-3,300
-13% -$64.8K
2019 Q3
7 quarters
MAS icon
181
Masco
MAS
$13.8B
$610K 0.14%
10,354
+6,380
+161% +$393K
2021 Q1
1 quarter
IDU icon
182
iShares US Utilities ETF
IDU
$1.44B
$597K 0.13%
7,605
-371
-5% -$30.1K
2020 Q2
4 quarters
PG icon
183
Procter & Gamble
PG
$355B
$575K 0.13%
+4,258
New +$576K
2021 Q2
0 quarters
MRK icon
184
Merck
MRK
$350B
$555K 0.13%
+7,081
New +$527K
2021 Q2
0 quarters
NVS icon
185
Novartis
NVS
$271B
$554K 0.12%
6,073
-7
-0.1% -$623
2016 Q4
18 quarters
VEU icon
186
Vanguard FTSE All-World ex-US ETF
VEU
$67.9B
$552K 0.12%
8,706
+69
+0.8% +$4.37K
2021 Q1
1 quarter
SPLV icon
187
Invesco S&P 500 Low Volatility ETF
SPLV
$7.11B
$537K 0.12%
8,813
+3,935
+81% +$239K
2020 Q3
3 quarters
SYY icon
188
Sysco
SYY
$38.9B
$523K 0.12%
6,721
+10
+0.1% +$808
2020 Q1
5 quarters
CLX icon
189
Clorox
CLX
$10.2B
$509K 0.11%
2,827
-293
-9% -$53.5K
2021 Q1
1 quarter
VVV icon
190
Valvoline
VVV
$3.85B
$500K 0.11%
15,413
+73
+0.5% +$2.27K
2020 Q4
2 quarters
TLH icon
191
iShares 10-20 Year Treasury Bond ETF
TLH
$11.4B
$488K 0.11%
3,320
+670
+25% +$96.1K
2021 Q1
1 quarter
VGK icon
192
Vanguard FTSE Europe ETF
VGK
$29.4B
$486K 0.11%
7,223
-1,042
-13% -$70.3K
2020 Q3
3 quarters
PWZ icon
193
Invesco California AMT-Free Municipal Bond ETF
PWZ
$1.16B
$480K 0.11%
17,078
+82
+0.5% +$2.3K
2020 Q2
4 quarters
EDIV icon
194
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.18B
$474K 0.11%
15,821
+1,017
+7% +$30.9K
2019 Q1
9 quarters
EFA icon
195
iShares MSCI EAFE ETF
EFA
$76.8B
$468K 0.11%
5,928
+1,109
+23% +$88.1K
2019 Q1
9 quarters
WDC icon
196
Western Digital
WDC
$143B
$463K 0.1%
+8,600
New +$465K
2021 Q2
0 quarters
PANA
197
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$461K 0.1%
+46,000
New +$461K
2021 Q2
0 quarters
DBC icon
198
Invesco DB Commodity Index Tracking Fund
DBC
$1.98B
$458K 0.1%
23,809
+500
+2% +$9.13K
2021 Q1
1 quarter
RTX icon
199
RTX Corp
RTX
$247B
$457K 0.1%
5,358
+1
+0% +$84
2020 Q2
4 quarters
MSCI icon
200
MSCI
MSCI
$40.8B
$436K 0.1%
818
+32
+4% +$15.3K
2019 Q3
7 quarters

Similar funds

Intellectus Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Intellectus Partners held 280 positions worth $443M, up 22% from $364M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Intellectus Partners deployed $58.1M of net new capital in Q2 2021, opening 38 new positions and adding to 121 existing holdings. Its largest new stake was AbCellera Biologics: 1,206,979 shares worth $26.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Intellia Therapeutics, an estimated $1.79M trimmed.

  • Intellectus Partners's largest Q2 2021 buy was AbCellera Biologics: 1,206,979 shares worth $26.6M.
  • Intellectus Partners added most to iShares Silver Trust in Q2 2021, an estimated $1.54M increase.
  • Intellectus Partners's biggest Q2 2021 reduction was Intellia Therapeutics, cutting an estimated $1.79M.
  • Intellectus Partners fully exited Virgin Galactic in Q2 2021, selling an estimated $1.1M.
  • Intellectus Partners's ten largest holdings make up 29% of its $443M portfolio in Q2 2021.
  • Intellectus Partners opened 38 new positions and closed 8 in Q2 2021.
  • Intellectus Partners's portfolio value rose 22% quarter-over-quarter to $443M.

Based on Intellectus Partners's 13F filing for Q2 2021, filed 13 Aug 2021.